Histopathologic Manifestations of Immune Checkpoint Inhibitor Therapy-Associated Gastrointestinal Tract Injury: A Practical Review.

Mitchell, James Michael; Karamchandani, Dipti M

Mitchell, James Michael; Karamchandani, Dipti M.

Afiliación

Mitchell JM; Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. Electronic address: https://twitter.com/GIJamesMD.
Karamchandani DM; Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. Electronic address: dipti.karamchandani@utsouthwestern.edu.

Surg Pathol Clin ; 16(4): 703-718, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37863561

Asunto(s)

Inhibidores de Puntos de Control Inmunológico; Neoplasias; Humanos; Inhibidores de Puntos de Control Inmunológico/efectos adversos; Tracto Gastrointestinal

Palabras clave

Cytotoxic T lymphocyte antigen (CTLA)-4; Immune checkpoint inhibitors; Immune-related adverse events; Programmed death (PD)-1; Programmed death ligand (PD-L1)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Límite: Humans Idioma: En Revista: Surg Pathol Clin Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google